Literature DB >> 1378272

Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine.

P A Bush1, N E Gonzalez, J M Griscavage, L J Ignarro.   

Abstract

This study examined whether constitutive nitric oxide (NO) synthase from rat cerebellum catalyzes the formation of equimolar amounts of NO plus citrulline from L-arginine under various conditions. Citrulline was determined by monitoring the formation of 3H-citrulline from 3H-L-arginine. NO was determined by monitoring the formation of total NOx (NO+nitrite [NO2-] + nitrate [NO3-]) by chemiluminescence after reduction of NOx to NO by acidic vanadium (III). Equal quantities of NO plus citrulline were generated from L-arginine and the formation of both products was linear for about 20 min at 37 degrees C provided L-arginine was present in excess to maintain a zero order reaction rate. Deletion of NADPH, addition of the calmodulin antagonist calmidazolium, or addition of NO synthase inhibitors (NG-methyl-L-arginine, NG-amino-L-arginine) abolished or markedly inhibited the formation of both NO and citrulline. The Km for L-arginine (14 microM; 18 microM) and the Vmax of the reaction (0.74 nmol/min/mg protein; 0.67 nmol/min/mg protein) were the same whether NO or citrulline formation, respectively, was monitored. These observations indicate clearly that NO and citrulline are formed in equimolar quantities from L-arginine by the constitutive isoform of NO synthase from rat cerebellum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1378272     DOI: 10.1016/0006-291x(92)91720-b

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  [Determination of NO-synthase activity in the brain (new method)].

Authors:  A I Tsapin; M Iu Stepanichev; M L Libe; N V Guliaeva
Journal:  Biull Eksp Biol Med       Date:  1994-01

Review 2.  Nitric oxide synthases in mammals.

Authors:  R G Knowles; S Moncada
Journal:  Biochem J       Date:  1994-03-01       Impact factor: 3.857

3.  Ozone enema: a model of microscopic colitis in rats.

Authors:  R Eliakim; F Karmeli; D Rachmilewitz; P Cohen; A Zimran
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

4.  Effects of exercise training on vasodilatory protein expression and activity in rats.

Authors:  Richard M McAllister; Elmer M Price
Journal:  Eur J Appl Physiol       Date:  2010-08-03       Impact factor: 3.078

5.  Inhibitors of the proteasome pathway interfere with induction of nitric oxide synthase in macrophages by blocking activation of transcription factor NF-kappa B.

Authors:  J M Griscavage; S Wilk; L J Ignarro
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.

Authors:  D Rachmilewitz; J S Stamler; D Bachwich; F Karmeli; Z Ackerman; D K Podolsky
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

7.  Hyperbaric oxygen: a novel modality to ameliorate experimental colitis.

Authors:  D Rachmilewitz; F Karmeli; E Okon; I Rubenstein; O S Better
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.

Authors:  K Morita; K Ihnken; G D Buckberg; M P Sherman; H H Young; L J Ignarro
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

9.  Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.

Authors:  D Rachmilewitz; F Karmeli; E Okon; M Bursztyn
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

10.  Oxidation of nitric oxide in aqueous solution to nitrite but not nitrate: comparison with enzymatically formed nitric oxide from L-arginine.

Authors:  L J Ignarro; J M Fukuto; J M Griscavage; N E Rogers; R E Byrns
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.